查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1881892

器官生理微系统市场报告：趋势、预测与竞争分析（至2031年）

Organ Physiological Microsystem Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球器官和生理微系统市场预计将成为一个充满前景的市场，这主要得益于製药和生物技术公司以及学术和研究机构的机会，预计从 2025 年到 2031 年，该市场将以 15% 的复合年增长率增长。关键成长要素包括对先进药物测试模型的需求不断增长、对个人化医疗研究的投资不断增加，以及器官晶片技术在医疗保健领域的应用日益广泛。

  • 根据 Lucintel 的预测，按类型划分，多器官系统预计在预测期内将呈现更高的成长率。
  • 从应用领域来看，製药和生技公司预计将呈现更高的成长率。
  • 从区域来看，预计亚太地区在预测期内将达到最高的成长率。

器官生理微系统（模拟器官系统）市场的新兴趋势

器官生理微系统市场正经历几项重大的新兴趋势，这些趋势正在从根本上重塑这个领域。这些趋势推动着技术从简单的器官模型向更复杂、整合和自动化的系统演进，从而为从药物研发到个人化医疗等广泛应用提供更准确、更具预测性的数据。

  • 多重器官系统的发展：一个显着的趋势是从单一器官晶片模型转向整合多器官系统，或所谓的「人体晶片」系统。这些平台将不同的器官模型（例如肝臟、肺臟和心臟）连接起来，以模拟它们之间的相互作用。这有助于全面了解药物的系统代谢、疗效和潜在毒性，从而提供一个更全面、更具预测性的临床前测试平台。
  • 先进感测器的整合：一种新兴趋势是将生物感测器和即时监测工具直接整合到晶片上。这些感测器可以即时测量各种生理参数，例如氧浓度、pH值和细胞电活动。这为研究人员提供了连续、高精度的数据，无需进行晶片外分析，从而提高了实验结果的通量和可靠性。
  • 利用患者来源的诱导多能干细胞：利用患者来源的诱导多功能细胞（iPS细胞）来建构器官模型是一项重要的研究趋势。使用患者自身的细胞可以创建个人化的疾病模型，从而准确反映个体独特的基因组成和生理反应。这代表着个人化医疗领域的突破，能够促进客製化治疗方法的开发和药物筛检。
  • 自动化与高通量筛检：市场正朝向自动化、高通量的晶片外检测（OOC）平台发展。各公司正在开发机器人系统和软体来处理晶片负载、培养基交换和资料收集。这种自动化减少了人工劳动，最大限度地减少了人为错误，并实现了对大量化合物的同步筛检，使OOC技术更具扩充性和实用性，更适用于製药业。
  • 疾病建模与治疗方法：利用体外器官系统（OOC）模拟特定人类疾病（包括神经系统疾病、癌症和感染疾病）的趋势日益增长。研究人员正在利用这些系统在生理相关环境中研究疾病机制并测试新型治疗化合物。这项应用对于加深我们对复杂疾病的理解以及加速新治疗方法的研发至关重要。

这些趋势正将OOC从一种小众研究工具扩充性为一个先进、可扩展且高度预测性的平台，服务製药和生物技术产业。研究重点正转向开发更贴近实际、更整合、更个人化的模型，以弥合临床前试验和临床试验之间的差距。

器官生理微系统市场的最新趋势

器官生理微系统市场正经历多项关键发展，这些发展推动了技术进步并扩大了应用范围。这些发展主要集中在提昇平台生理相关性、扩充性和预测能力，而这些对于平台在药物开发和研发领域的更广泛应用至关重要。

  • 先进的多器官系统：近期的一项重大进展是更先进的晶片多器官系统平台的开发和商业化。例如，一家公司推出了一种「肠-肝-脑」系统，使研究人员能够同时研究药物代谢及其神经系统效应。这项进步能够更全面地展现药物的系统性效应，并在毒性测试领域日益受到关注。
  • 新型材料和製造技术：用于製造这些晶片的材料正在取得重大进展。研究人员正在利用新型聚合物和生物材料，这些材料能够更精确地模拟活体组织环境，并支持原代细胞的长期培养。这些材料创新提高了体外细胞培养（OOC）模型的生物学保真度和稳定性，从而获得更可靠、更可重复的结果。
  • 人工智慧在数据分析中的应用：一项关键进展是将人工智慧 (AI) 和机器学习技术应用于分析 OOC 实验产生的大量数据。 AI 演算法可以处理即时感测器数据和影像分析，从而识别细胞行为的细微变化，并更准确地预测药物反应。这使得 OOC 平台在药物筛检更加强大和高效。
  • 标准化和检验工作：产业联盟和监管机构正积极致力于标准化体外检测（OOC）平台并制定检验指南。例如，一家生技公司与监管机构近期合作，旨在检验一个用于预测肝毒性的OOC模型。这项进展对于建立信任以及推动OOC数据在监管申报中获得正式认可至关重要。
  • 拓展至临床应用：儘管晶片肿瘤技术（OOC）主要用于临床前研究，但如今它正逐步应用于临床。近期案例包括利用患者来源的肿瘤晶片测试多种抗癌药物，以确定对特定患者最有效的药物，展现了该技术在个人化医疗领域的潜力。

这些进展正在透过加速技术的成熟和可靠性来影响市场。重点在于推动OOC平台从概念验证阶段过渡到检验和标准化的工具，从而促进其融入药物开发和临床工作流程，预计将节省时间和资源。

目录

第一章执行摘要

第二章 市场概览

  • 背景和分类
  • 供应链

第三章：市场趋势与预测分析

  • 产业驱动因素与挑战
  • PESTLE分析
  • 专利分析
  • 法规环境

4. 全球器官生理微系统市场（依类型划分）

  • 吸引力分析：按类型
  • 单一器官系统
  • 多重器官系统

5. 全球器官生理微系统市场（依应用划分）

  • 吸引力分析：依目的
  • 製药和生物技术公司
  • 学术和研究机构
  • 其他的

第六章 区域分析

7. 北美器官生理微系统市场

  • 北美器官生理微系统市场（按类型划分）
  • 北美器官生理微系统市场（依应用划分）
  • 美国器官生理微系统市场
  • 墨西哥器官生理微系统市场
  • 加拿大器官生理微系统市场

8. 欧洲器官生理微系统市场

  • 欧洲器官生理微系统市场（按类型划分）
  • 欧洲器官生理微系统市场（依应用划分）
  • 德国器官生理微系统市场
  • 法国器官生理微系统市场
  • 西班牙器官生理微系统市场
  • 义大利器官生理微系统市场
  • 英国器官生理微系统市场

9. 亚太地区器官生理微系统市场

  • 亚太地区器官生理微系统市场（依类型划分）
  • 亚太地区器官生理微系统市场（依应用划分）
  • 日本器官与生理显微系统市场
  • 印度器官生理微系统市场
  • 中国器官生理微系统市场
  • 韩国器官生理微系统市场
  • 印尼器官生理微系统市场

10. 其他地区（ROW）器官生理微系统市场

  • ROW器官生理微系统市场依类型划分
  • ROW器官生理微系统市场依应用领域划分
  • 中东器官生理微系统市场
  • 南美洲器官生理微系统市场
  • 非洲器官生理微系统市场

第十一章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析
  • 市占率分析

第十二章：机会与策略分析

  • 价值链分析
  • 成长机会分析
  • 全球器官生理微系统市场新兴趋势
  • 战略分析

第十三章：价值链中主要企业的概况

  • 竞争分析
  • Emulate
  • Draper Laboratory
  • Mimetas
  • TissUse
  • CN Bio
  • Hesperos
  • Nortis
  • Micronit
  • Kirkstall
  • Bi/ond

第十四章附录

The future of the global organ physiological microsystem market looks promising with opportunities in the pharmaceutical & biotechnology company and academic & research institute markets. The global organ physiological microsystem market is expected to grow with a CAGR of 15% from 2025 to 2031. The major drivers for this market are the increasing demand for advanced drug testing models, the rising investments in personalized medicine research, and the growing adoption of organ-on-chip technology in healthcare.

  • Lucintel forecasts that, within the type category, multi-organ system is expected to witness higher growth over the forecast period.
  • Within the application category, pharmaceutical & biotechnology company is expected to witness higher growth.
  • In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Organ Physiological Microsystem Market

The organ physiological microsystem market is experiencing several key emerging trends that are fundamentally reshaping the field. These trends are moving the technology beyond simple organ models to more complex, integrated, and automated systems that provide more accurate and predictive data for a range of applications, from drug discovery to personalized medicine.

  • Development of Multi-Organ Systems: A significant trend is the move from single-organ-on-a-chip models to integrated multi-organ or "human-on-a-chip" systems. These platforms connect different organ models, such as the liver, lung, and heart, to simulate organ-organ interactions. This enables a more comprehensive understanding of systemic drug metabolism, efficacy, and potential toxicity, providing a more holistic and predictive preclinical testing platform.
  • Integration of Advanced Sensors: An emerging trend is the integration of biosensors and real-time monitoring tools directly onto the chips. These sensors can measure various physiological parameters, such as oxygen levels, pH, and cellular electrical activity, in real-time. This provides researchers with continuous, high-fidelity data, eliminating the need for off-chip analysis and enhancing the throughput and reliability of experimental results.
  • Use of Patient-Derived iPSCs: The use of patient-derived induced pluripotent stem cells (iPSCs) to create organ models is a key trend. By using a patient's own cells, researchers can create personalized disease models that accurately reflect an individual's unique genetic makeup and physiological response. This is a game-changer for personalized medicine, enabling the development of tailored therapies and drug screening.
  • Automation and High-Throughput Screening: The market is seeing a push for automated and high-throughput OOC platforms. Companies are developing robotic systems and software to handle chip loading, media exchange, and data collection. This automation reduces manual labor, minimizes human error, and allows for the screening of a large number of compounds simultaneously, making OOC technology more scalable and practical for the pharmaceutical industry.
  • Disease Modeling and Therapeutics: A growing trend is the use of OOCs to model specific human diseases, such as neurological disorders, cancer, and infectious diseases. Researchers are using these systems to study disease mechanisms and test new therapeutic compounds in a physiologically relevant environment. This application is crucial for advancing our understanding of complex diseases and accelerating the development of new treatments.

These trends are reshaping the market by transforming OOCs from a niche research tool into a sophisticated, scalable, and highly predictive platform for the pharmaceutical and biotechnology industries. The focus is shifting towards creating more realistic, integrated, and personalized models that can bridge the gap between preclinical and clinical trials.

Recent Developments in the Organ Physiological Microsystem Market

The organ physiological microsystem market has seen several key developments that are advancing the technology and expanding its applications. These developments are focused on improving the physiological relevance, scalability, and predictive power of these platforms, which is crucial for their wider adoption in drug development and research.

  • Advanced Multi-Organ Systems: A major recent development is the creation and commercialization of more sophisticated multi-organ-on-a-chip platforms. For example, a company might launch a "gut-liver-brain" system that allows for the study of drug metabolism and its neurological effects simultaneously. This advancement provides a more complete picture of a drug's systemic impact and is gaining traction for toxicology testing.
  • Novel Materials and Fabrication: There have been significant developments in the materials used to create these chips. Researchers are using new polymers and biomaterials that better mimic the native tissue environment and support the long-term culture of primary cells. These material innovations are enhancing the biological fidelity and stability of OOC models, leading to more reliable and reproducible results.
  • AI Integration for Data Analysis: A key development is the integration of artificial intelligence (AI) and machine learning for analyzing the vast amount of data generated by OOC experiments. AI algorithms can process real-time sensor data and image analysis to identify subtle changes in cellular behavior and predict drug responses more accurately. This makes OOC platforms more powerful and efficient for drug screening.
  • Standardization and Validation Initiatives: Industry consortia and regulatory bodies are actively working on standardizing OOC platforms and establishing validation guidelines. For example, a recent collaboration between a biotech firm and a regulatory agency might aim to validate an OOC model for predicting liver toxicity. This development is crucial for building trust and enabling the formal acceptance of OOC data in regulatory submissions.
  • Expansion into Clinical Applications: While primarily used in preclinical research, OOC technology is now seeing its first clinical applications. A recent development could be a study using a patient-derived tumor-on-a-chip to test a panel of cancer drugs to determine which is most effective for that specific patient. This demonstrates the technology's potential for personalized medicine.

These developments are impacting the market by accelerating the technology's maturity and credibility. The focus is on moving OOC platforms from a proof-of-concept stage to a validated, standardized tool that is increasingly integrated into the drug development and clinical workflow, promising to save time and resources.

Strategic Growth Opportunities in the Organ Physiological Microsystem Market

The organ physiological microsystem market offers significant strategic growth opportunities by leveraging its unique ability to mimic human physiology. These opportunities are concentrated in high-value applications where OOC technology can provide a superior alternative to traditional models, thereby addressing critical needs in drug development and personalized healthcare.

  • Drug Discovery and Efficacy Testing: The most significant opportunity lies in replacing or complementing traditional animal models for drug discovery. OOCs can provide more human-relevant data on a drug's efficacy and mechanism of action early in the development process. This can help pharmaceutical companies to screen compounds more effectively, reducing the high rate of drug failure in clinical trials and saving billions in R&D costs.
  • Toxicology and Safety Assessment: OOC platforms offer a powerful tool for toxicology testing, particularly for organs like the liver, heart, and kidney. Companies can use these models to test for potential organ toxicity of new compounds in a controlled, human-relevant environment, which is a major regulatory requirement. This application is a key growth area, especially with the global push to reduce animal testing.
  • Personalized and Precision Medicine: A major strategic opportunity is the use of OOCs for personalized medicine. By using patient-derived cells, researchers can create "patient-on-a-chip" models to test which treatments are most effective for an individual. This can revolutionize the treatment of diseases like cancer, enabling doctors to select the best therapy and avoid ineffective or toxic drugs.
  • Disease Modeling and Pathogenesis Studies: OOC platforms are an excellent tool for modeling human diseases, from genetic disorders to infectious diseases. By recreating the physiological environment of a diseased organ, researchers can study disease progression and test new therapeutic strategies. This application is crucial for advancing our fundamental understanding of human biology and developing targeted treatments.
  • Cosmetics and Chemical Testing: The cosmetics and consumer goods industries present a significant growth opportunity due to a growing demand for cruelty-free and animal-free testing methods. OOC platforms can be used to test the safety of cosmetic ingredients and chemicals on a human-relevant model, ensuring product safety and meeting evolving consumer and regulatory expectations.

These growth opportunities are impacting the market by highlighting the technology's value proposition across multiple sectors. The focus is on transitioning OOCs from an academic tool to an essential, commercially viable platform that can address major bottlenecks in drug development, improve patient outcomes, and promote ethical testing practices.

Organ Physiological Microsystem Market Driver and Challenges

The organ physiological microsystem market is shaped by a confluence of technological, economic, and regulatory factors. The market's growth is primarily driven by the need for more efficient and ethical methods of drug testing, while its expansion is hindered by significant technical and commercial challenges that must be overcome for widespread adoption.

The factors responsible for driving the organ physiological microsystem market include:

1. Need for Predictive Human Models: The high failure rate of drugs in clinical trials, largely due to poor translation from animal models to humans, is a primary driver. OOC platforms offer a more physiologically relevant and predictive alternative, providing a better understanding of drug efficacy and toxicity in human-like systems before human trials.

2. Growing Focus on Personalized Medicine: The increasing demand for personalized medicine is a key driver. OOCs can be created using a patient's own cells, allowing for the testing of various drug therapies to determine the most effective treatment for that individual. This is a powerful tool for tailoring medicine to specific patients.

3. Reducing Animal Testing: There is a global push, driven by ethical concerns and regulatory changes, to reduce or replace animal testing. OOCs provide a viable alternative that can generate human-relevant data without the use of live animals, making them an attractive option for pharmaceutical, cosmetic, and chemical industries.

4. Technological Advancements: Continuous innovations in microfluidics, biomaterials, and cell culture techniques are driving the market forward. These advancements have enabled the creation of more complex and physiologically realistic OOC models, with integrated sensors and automation capabilities, making the technology more robust and scalable for industrial applications.

5. High Cost of Drug Discovery: The high cost and long timelines of traditional drug discovery are major drivers. By enabling earlier and more accurate screening of drug candidates, OOCs can help companies de-risk their R&D pipelines, reduce late-stage failures, and ultimately lower the overall cost of bringing a new drug to market.

Challenges in the organ physiological microsystem market are:

1. Standardization and Validation: A major challenge is the lack of standardized protocols and validation guidelines for OOC platforms. Variations in chip design, cell sources, and experimental procedures can lead to inconsistent results, making it difficult for regulatory bodies to accept the data and for the industry to adopt the technology on a large scale.

2. High Cost of Platforms: The high initial cost of OOC platforms, including the specialized instrumentation, consumables, and skilled personnel required to operate them, is a significant barrier to widespread adoption. This high cost can be prohibitive for smaller research labs and biotech startups.

3. Replicating Complex Human Physiology: Despite advancements, OOCs still struggle to fully replicate the complexity of the human body, including the immune system, endocrine signaling, and the intricate interaction of multiple organ systems. This limitation means they cannot completely replace animal models for all applications, posing a key challenge for their future growth.

The organ physiological microsystem market is driven by the urgent need for more predictive, cost-effective, and ethical drug development tools. However, its growth is constrained by the challenges of standardization, high costs, and the inherent difficulty of fully replicating human biological complexity. The market's future success depends on addressing these challenges to build trust and achieve widespread adoption.

List of Organ Physiological Microsystem Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies organ physiological microsystem companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the organ physiological microsystem companies profiled in this report include-

  • Emulate
  • Draper Laboratory
  • Mimetas
  • TissUse
  • CN Bio
  • Hesperos
  • Nortis
  • Micronit
  • Kirkstall
  • Bi/ond

Organ Physiological Microsystem Market by Segment

The study includes a forecast for the global organ physiological microsystem market by type, application, and region.

Organ Physiological Microsystem Market by Type [Value from 2019 to 2031]:

  • Single-organ System
  • Multi-organ System

Organ Physiological Microsystem Market by Application [Value from 2019 to 2031]:

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Others

Country Wise Outlook for the Organ Physiological Microsystem Market

The organ physiological microsystem market, encompassing technologies like Organ-on-a-Chip (OOC), is experiencing rapid growth as it revolutionizes drug discovery, toxicology, and personalized medicine. This market is driven by the urgent need for more predictive, human-relevant models that can reduce the reliance on animal testing and lower the high cost of drug development. These platforms offer a more accurate way to model human physiology and disease.

  • United States: The U.S. is a dominant player, with significant R&D investment from government agencies like the NIH and FDA, and major private sector funding. This has led to the development of advanced multi-organ chips and human-on-a-chip platforms. The focus is on integrating these systems into the drug development pipeline to improve the predictability of clinical trial outcomes and expedite the approval process for new therapies.
  • China: China is rapidly expanding its presence in the market, driven by substantial government investment in biotechnology and a growing life sciences sector. Researchers and companies are focused on developing their own OOC technologies, particularly for applications in disease modeling and toxicology testing. The country aims to reduce its reliance on international technologies and establish a strong domestic market.
  • Germany: Germany is a key hub for OOC technology in Europe, leveraging its strong expertise in biomedical engineering and microfluidics. The market is supported by a robust research ecosystem with collaborations between universities and biotech companies. The focus is on creating highly realistic organ models, with recent research efforts aimed at integrating vascular systems to improve the physiological relevance of these platforms.
  • India: India is emerging as a growth market, with increasing investment in biotechnology and a focus on cost-effective drug discovery and development. The market for OOCs is being driven by the need for alternatives to animal testing and a push for more efficient preclinical research. Academic institutions and startups are leading the development of indigenous OOC technologies.
  • Japan: Japan's market is characterized by a strong emphasis on regenerative medicine and advanced cell culture techniques. Researchers and companies are developing OOC models using human-induced pluripotent stem cells (iPSCs) to create patient-specific disease models. This focus on personalized medicine and regenerative therapies is a key driver for the adoption of sophisticated physiological microsystems.

Features of the Global Organ Physiological Microsystem Market

  • Market Size Estimates: Organ physiological microsystem market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Organ physiological microsystem market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Organ physiological microsystem market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the organ physiological microsystem market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the organ physiological microsystem market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the organ physiological microsystem market by type (single-organ system and multi-organ system), application (pharmaceutical & biotechnology companies, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Organ Physiological Microsystem Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Single-organ System: Trends and Forecast (2019-2031)
  • 4.4 Multi-organ System: Trends and Forecast (2019-2031)

5. Global Organ Physiological Microsystem Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Pharmaceutical & Biotechnology Companies: Trends and Forecast (2019-2031)
  • 5.4 Academic & Research Institutes: Trends and Forecast (2019-2031)
  • 5.5 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Organ Physiological Microsystem Market by Region

7. North American Organ Physiological Microsystem Market

  • 7.1 Overview
  • 7.2 North American Organ Physiological Microsystem Market by Type
  • 7.3 North American Organ Physiological Microsystem Market by Application
  • 7.4 United States Organ Physiological Microsystem Market
  • 7.5 Mexican Organ Physiological Microsystem Market
  • 7.6 Canadian Organ Physiological Microsystem Market

8. European Organ Physiological Microsystem Market

  • 8.1 Overview
  • 8.2 European Organ Physiological Microsystem Market by Type
  • 8.3 European Organ Physiological Microsystem Market by Application
  • 8.4 German Organ Physiological Microsystem Market
  • 8.5 French Organ Physiological Microsystem Market
  • 8.6 Spanish Organ Physiological Microsystem Market
  • 8.7 Italian Organ Physiological Microsystem Market
  • 8.8 United Kingdom Organ Physiological Microsystem Market

9. APAC Organ Physiological Microsystem Market

  • 9.1 Overview
  • 9.2 APAC Organ Physiological Microsystem Market by Type
  • 9.3 APAC Organ Physiological Microsystem Market by Application
  • 9.4 Japanese Organ Physiological Microsystem Market
  • 9.5 Indian Organ Physiological Microsystem Market
  • 9.6 Chinese Organ Physiological Microsystem Market
  • 9.7 South Korean Organ Physiological Microsystem Market
  • 9.8 Indonesian Organ Physiological Microsystem Market

10. ROW Organ Physiological Microsystem Market

  • 10.1 Overview
  • 10.2 ROW Organ Physiological Microsystem Market by Type
  • 10.3 ROW Organ Physiological Microsystem Market by Application
  • 10.4 Middle Eastern Organ Physiological Microsystem Market
  • 10.5 South American Organ Physiological Microsystem Market
  • 10.6 African Organ Physiological Microsystem Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global Organ Physiological Microsystem Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 Emulate
    • Company Overview
    • Organ Physiological Microsystem Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Draper Laboratory
    • Company Overview
    • Organ Physiological Microsystem Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Mimetas
    • Company Overview
    • Organ Physiological Microsystem Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 TissUse
    • Company Overview
    • Organ Physiological Microsystem Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 CN Bio
    • Company Overview
    • Organ Physiological Microsystem Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 Hesperos
    • Company Overview
    • Organ Physiological Microsystem Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 Nortis
    • Company Overview
    • Organ Physiological Microsystem Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.9 Micronit
    • Company Overview
    • Organ Physiological Microsystem Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.10 Kirkstall
    • Company Overview
    • Organ Physiological Microsystem Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.11 Bi/ond
    • Company Overview
    • Organ Physiological Microsystem Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Organ Physiological Microsystem Market
  • Figure 2.1: Usage of Organ Physiological Microsystem Market
  • Figure 2.2: Classification of the Global Organ Physiological Microsystem Market
  • Figure 2.3: Supply Chain of the Global Organ Physiological Microsystem Market
  • Figure 3.1: Driver and Challenges of the Organ Physiological Microsystem Market
  • Figure 3.2: PESTLE Analysis
  • Figure 3.3: Patent Analysis
  • Figure 3.4: Regulatory Environment
  • Figure 4.1: Global Organ Physiological Microsystem Market by Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global Organ Physiological Microsystem Market ($B) by Type
  • Figure 4.3: Forecast for the Global Organ Physiological Microsystem Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Single-organ System in the Global Organ Physiological Microsystem Market (2019-2031)
  • Figure 4.5: Trends and Forecast for Multi-organ System in the Global Organ Physiological Microsystem Market (2019-2031)
  • Figure 5.1: Global Organ Physiological Microsystem Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global Organ Physiological Microsystem Market ($B) by Application
  • Figure 5.3: Forecast for the Global Organ Physiological Microsystem Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Pharmaceutical & Biotechnology Companies in the Global Organ Physiological Microsystem Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Academic & Research Institutes in the Global Organ Physiological Microsystem Market (2019-2031)
  • Figure 5.6: Trends and Forecast for Others in the Global Organ Physiological Microsystem Market (2019-2031)
  • Figure 6.1: Trends of the Global Organ Physiological Microsystem Market ($B) by Region (2019-2024)
  • Figure 6.2: Forecast for the Global Organ Physiological Microsystem Market ($B) by Region (2025-2031)
  • Figure 7.1: North American Organ Physiological Microsystem Market by Type in 2019, 2024, and 2031
  • Figure 7.2: Trends of the North American Organ Physiological Microsystem Market ($B) by Type (2019-2024)
  • Figure 7.3: Forecast for the North American Organ Physiological Microsystem Market ($B) by Type (2025-2031)
  • Figure 7.4: North American Organ Physiological Microsystem Market by Application in 2019, 2024, and 2031
  • Figure 7.5: Trends of the North American Organ Physiological Microsystem Market ($B) by Application (2019-2024)
  • Figure 7.6: Forecast for the North American Organ Physiological Microsystem Market ($B) by Application (2025-2031)
  • Figure 7.7: Trends and Forecast for the United States Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 7.8: Trends and Forecast for the Mexican Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 7.9: Trends and Forecast for the Canadian Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 8.1: European Organ Physiological Microsystem Market by Type in 2019, 2024, and 2031
  • Figure 8.2: Trends of the European Organ Physiological Microsystem Market ($B) by Type (2019-2024)
  • Figure 8.3: Forecast for the European Organ Physiological Microsystem Market ($B) by Type (2025-2031)
  • Figure 8.4: European Organ Physiological Microsystem Market by Application in 2019, 2024, and 2031
  • Figure 8.5: Trends of the European Organ Physiological Microsystem Market ($B) by Application (2019-2024)
  • Figure 8.6: Forecast for the European Organ Physiological Microsystem Market ($B) by Application (2025-2031)
  • Figure 8.7: Trends and Forecast for the German Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 8.8: Trends and Forecast for the French Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the Spanish Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 8.10: Trends and Forecast for the Italian Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 8.11: Trends and Forecast for the United Kingdom Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 9.1: APAC Organ Physiological Microsystem Market by Type in 2019, 2024, and 2031
  • Figure 9.2: Trends of the APAC Organ Physiological Microsystem Market ($B) by Type (2019-2024)
  • Figure 9.3: Forecast for the APAC Organ Physiological Microsystem Market ($B) by Type (2025-2031)
  • Figure 9.4: APAC Organ Physiological Microsystem Market by Application in 2019, 2024, and 2031
  • Figure 9.5: Trends of the APAC Organ Physiological Microsystem Market ($B) by Application (2019-2024)
  • Figure 9.6: Forecast for the APAC Organ Physiological Microsystem Market ($B) by Application (2025-2031)
  • Figure 9.7: Trends and Forecast for the Japanese Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 9.8: Trends and Forecast for the Indian Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Chinese Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the South Korean Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the Indonesian Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 10.1: ROW Organ Physiological Microsystem Market by Type in 2019, 2024, and 2031
  • Figure 10.2: Trends of the ROW Organ Physiological Microsystem Market ($B) by Type (2019-2024)
  • Figure 10.3: Forecast for the ROW Organ Physiological Microsystem Market ($B) by Type (2025-2031)
  • Figure 10.4: ROW Organ Physiological Microsystem Market by Application in 2019, 2024, and 2031
  • Figure 10.5: Trends of the ROW Organ Physiological Microsystem Market ($B) by Application (2019-2024)
  • Figure 10.6: Forecast for the ROW Organ Physiological Microsystem Market ($B) by Application (2025-2031)
  • Figure 10.7: Trends and Forecast for the Middle Eastern Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 10.8: Trends and Forecast for the South American Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the African Organ Physiological Microsystem Market ($B) (2019-2031)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Organ Physiological Microsystem Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Organ Physiological Microsystem Market (2024)
  • Figure 12.1: Growth Opportunities for the Global Organ Physiological Microsystem Market by Type
  • Figure 12.2: Growth Opportunities for the Global Organ Physiological Microsystem Market by Application
  • Figure 12.3: Growth Opportunities for the Global Organ Physiological Microsystem Market by Region
  • Figure 12.4: Emerging Trends in the Global Organ Physiological Microsystem Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Organ Physiological Microsystem Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Organ Physiological Microsystem Market by Region
  • Table 1.3: Global Organ Physiological Microsystem Market Parameters and Attributes
  • Table 3.1: Trends of the Global Organ Physiological Microsystem Market (2019-2024)
  • Table 3.2: Forecast for the Global Organ Physiological Microsystem Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global Organ Physiological Microsystem Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Organ Physiological Microsystem Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Organ Physiological Microsystem Market (2025-2031)
  • Table 4.4: Trends of Single-organ System in the Global Organ Physiological Microsystem Market (2019-2024)
  • Table 4.5: Forecast for Single-organ System in the Global Organ Physiological Microsystem Market (2025-2031)
  • Table 4.6: Trends of Multi-organ System in the Global Organ Physiological Microsystem Market (2019-2024)
  • Table 4.7: Forecast for Multi-organ System in the Global Organ Physiological Microsystem Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global Organ Physiological Microsystem Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Organ Physiological Microsystem Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Organ Physiological Microsystem Market (2025-2031)
  • Table 5.4: Trends of Pharmaceutical & Biotechnology Companies in the Global Organ Physiological Microsystem Market (2019-2024)
  • Table 5.5: Forecast for Pharmaceutical & Biotechnology Companies in the Global Organ Physiological Microsystem Market (2025-2031)
  • Table 5.6: Trends of Academic & Research Institutes in the Global Organ Physiological Microsystem Market (2019-2024)
  • Table 5.7: Forecast for Academic & Research Institutes in the Global Organ Physiological Microsystem Market (2025-2031)
  • Table 5.8: Trends of Others in the Global Organ Physiological Microsystem Market (2019-2024)
  • Table 5.9: Forecast for Others in the Global Organ Physiological Microsystem Market (2025-2031)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Organ Physiological Microsystem Market (2019-2024)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Organ Physiological Microsystem Market (2025-2031)
  • Table 7.1: Trends of the North American Organ Physiological Microsystem Market (2019-2024)
  • Table 7.2: Forecast for the North American Organ Physiological Microsystem Market (2025-2031)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Organ Physiological Microsystem Market (2019-2024)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Organ Physiological Microsystem Market (2025-2031)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Organ Physiological Microsystem Market (2019-2024)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Organ Physiological Microsystem Market (2025-2031)
  • Table 7.7: Trends and Forecast for the United States Organ Physiological Microsystem Market (2019-2031)
  • Table 7.8: Trends and Forecast for the Mexican Organ Physiological Microsystem Market (2019-2031)
  • Table 7.9: Trends and Forecast for the Canadian Organ Physiological Microsystem Market (2019-2031)
  • Table 8.1: Trends of the European Organ Physiological Microsystem Market (2019-2024)
  • Table 8.2: Forecast for the European Organ Physiological Microsystem Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various Type in the European Organ Physiological Microsystem Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various Type in the European Organ Physiological Microsystem Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various Application in the European Organ Physiological Microsystem Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various Application in the European Organ Physiological Microsystem Market (2025-2031)
  • Table 8.7: Trends and Forecast for the German Organ Physiological Microsystem Market (2019-2031)
  • Table 8.8: Trends and Forecast for the French Organ Physiological Microsystem Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Spanish Organ Physiological Microsystem Market (2019-2031)
  • Table 8.10: Trends and Forecast for the Italian Organ Physiological Microsystem Market (2019-2031)
  • Table 8.11: Trends and Forecast for the United Kingdom Organ Physiological Microsystem Market (2019-2031)
  • Table 9.1: Trends of the APAC Organ Physiological Microsystem Market (2019-2024)
  • Table 9.2: Forecast for the APAC Organ Physiological Microsystem Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Organ Physiological Microsystem Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Organ Physiological Microsystem Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Organ Physiological Microsystem Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Organ Physiological Microsystem Market (2025-2031)
  • Table 9.7: Trends and Forecast for the Japanese Organ Physiological Microsystem Market (2019-2031)
  • Table 9.8: Trends and Forecast for the Indian Organ Physiological Microsystem Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Chinese Organ Physiological Microsystem Market (2019-2031)
  • Table 9.10: Trends and Forecast for the South Korean Organ Physiological Microsystem Market (2019-2031)
  • Table 9.11: Trends and Forecast for the Indonesian Organ Physiological Microsystem Market (2019-2031)
  • Table 10.1: Trends of the ROW Organ Physiological Microsystem Market (2019-2024)
  • Table 10.2: Forecast for the ROW Organ Physiological Microsystem Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Organ Physiological Microsystem Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Organ Physiological Microsystem Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Organ Physiological Microsystem Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Organ Physiological Microsystem Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Middle Eastern Organ Physiological Microsystem Market (2019-2031)
  • Table 10.8: Trends and Forecast for the South American Organ Physiological Microsystem Market (2019-2031)
  • Table 10.9: Trends and Forecast for the African Organ Physiological Microsystem Market (2019-2031)
  • Table 11.1: Product Mapping of Organ Physiological Microsystem Suppliers Based on Segments
  • Table 11.2: Operational Integration of Organ Physiological Microsystem Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Organ Physiological Microsystem Revenue
  • Table 12.1: New Product Launches by Major Organ Physiological Microsystem Producers (2019-2024)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Organ Physiological Microsystem Market